AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 inter alia to consider and approve We hereby inform pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that a Meeting of the Board of Directors of the Company will be held on Tuesday November 12 2019 to consider and approve inter alia the following:
1. Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2019.
2. Payment of Interim Dividend if any for the financial year 2019-20.
Further to our letter dated September 26 2019 informing the closure of Trading Window of the Company from October 1 2019 until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the second quarter ended September 30 2019 we inform you that the Trading Window will remain closed up to November 14 2019 and shall be re-opened on November 15 2019.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
